The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2022 | Unmet needs in patients with AA amyloidosis with renal involvement
Peter Kvacskay, MD, Heidelberg University Hospital, Heidelberg, Germany, highlights the main unmet needs in patients with AA amyloidosis with renal involvement, including preventing patients from developing amyloidosis and amyloidosis-related organ damage, and developing effective therapies to target fibrosis in these patients. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
